ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia
Abstract MLL-rearranged acute myeloid leukemia (AML) remains a fatal disease with a high rate of relapse and therapeutic failure due to chemotherapy resistance. In analysis of our Affymetrix microarray profiling and chromatin immunoprecipitation (ChIP) assays, we found that ALOX5 is especially down-...
Saved in:
Main Authors: | Yungui Wang, Jennifer R. Skibbe, Chao Hu, Lei Dong, Kyle Ferchen, Rui Su, Chenying Li, Hao Huang, Hengyou Weng, Huilin Huang, Xi Qin, Jie Jin, Jianjun Chen, Xi Jiang |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/f693c34a5ab845d5aef3a46dd809a2a8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML
by: Yue Sheng, et al.
Published: (2020) -
MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia
by: Svetlana S. Itskovich, et al.
Published: (2020) -
MiRNA-495 regulates proliferation and apoptosis of acute myeloid leukemia cells with MLL gene rearrangement by targeting STYX
by: YANG Rui, et al.
Published: (2021) -
Publisher Correction: MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia
by: Svetlana S. Itskovich, et al.
Published: (2020) -
Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
by: Xi Jiang, et al.
Published: (2017)